Oxidative and Nitrosative Stress as Symptom Amplifier
The nitric oxide/peroxynitrite (NO/ONOO-) cycle and reactive oxygen species (ROS) amplify symptom production across multiple domains: mitochondrial uncoupling, protein nitration, membrane lipid peroxidation, and TRP channel sensitization. This section presents Martin Pall’s NO/ONOO- cycle hypothesis in the context of current evidence, covers ROS-induced transient receptor potential (TRP) channel activation as a pain amplifier, and connects oxidative stress to the neuroinflammatory cascade, explaining why antioxidant strategies have shown partial but inconsistent benefit.
1 The NO/ONOO- Vicious Cycle
Martin Pall proposed that ME/CFS is initiated when short-term stressors (infection, trauma, chemical exposure) induce pro-inflammatory cytokines (IL-1\(\beta\), IL-6, TNF-\(\alpha\), IFN-\(\gamma\)) that upregulate inducible nitric oxide synthase (iNOS), elevating nitric oxide (Pall 2000). Nitric oxide reacts with superoxide to form peroxynitrite (ONOO-), a potent oxidant that damages proteins, lipids and DNA. Pall proposed six positive feedback loops sustaining elevated ONOO-: NF-\(\kappa\)B activation (increasing iNOS), NMDA receptor sensitization, mitochondrial complex I/III electron leakage (generating more superoxide), tetrahydrobiopterin (BH4) depletion via ONOO- oxidation (causing NOS uncoupling, converting NOS into a peroxynitrite synthase), and HPA axis suppression via lowered glucocorticoid production (Pall 2001). This mechanism — named the NO/ONOO- cycle — predicts that agents lowering multiple cycle elements simultaneously (antioxidants, NMDA antagonists, anti-inflammatory compounds) would be required for therapeutic benefit. (Certainty: Low; Medical Hypotheses journal, not empirically tested in RCTs; mechanistically plausible and consistent with downstream evidence.)
2 Glutathione Depletion and Oxidative Burden
Empirical support for oxidative stress as a disease mechanism in ME/CFS comes from neuroimaging studies. Proton magnetic resonance spectroscopy documented significantly reduced cortical glutathione (GSH) in ME/CFS patients compared with controls, with a strong inverse correlation between ventricular lactate and cortical GSH (\(r = -0.545\), \(p = 0.001\)), and significant positive correlations between GSH and physical functioning (\(\rho = 0.506\), \(p = 0.001\)) and energy levels (\(\rho = 0.606\), \(p < 0.001\)) (Dikoma C. Shungu et al. 2012). A pilot trial of N-acetylcysteine (NAC) at 1800mg/day for four weeks normalized cortical GSH, ventricular lactate and symptom scores, providing proof-of-concept that GSH repletion via NAC crosses the blood–brain barrier (D. C. Shungu 2016).
3 TRP Channel Sensitization by ROS
Reactive oxygen species activate transient receptor potential channels directly: TRPV1 (vanilloid 1, the capsaicin receptor) and TRPA1 (ankyrin 1, activated by oxidant products such as 4-hydroxynonenal and acrolein) function as cellular danger sensors, translating oxidative stress into nociceptive signaling (Macpherson et al. 2007). In the context of neurogenic inflammation, CGRP-driven TRPA1 activation in Schwann cells sustains mechanical allodynia independently of direct neuronal injury, providing a peripheral amplification loop for central sensitization.
TRPV1 activation is self-amplifying: stimulation upregulates COX2 (cyclooxygenase-2) in primary sensory neurons within approximately 30 minutes, generating prostaglandins that re-sensitize TRPV1 via EP1 and IP G-protein-coupled receptors (Li et al. 2021) (Moriyama et al. 2005). This feed-forward loop means that a single triggering event — heat, acidosis, a capsaicin-like food compound, or an ROS burst during exertion — can establish a sustained sensitized state lasting hours, even after the initial trigger is removed. In ME/CFS, where prostaglandin production is chronically elevated and ROS clearance is impaired, this loop may operate constitutively, maintaining continuous low-grade TRPV1-driven nociceptor activation without requiring repeated external triggers.
Similarly, TRPA1 serves as a molecular sensor for oxidative tissue damage: it is activated by direct covalent modification of reactive cytosolic cysteine residues by H2O2, acrolein, 4-hydroxynonenal, and other electrophilic oxidative stress metabolites (Macpherson et al. 2007). In ME/CFS, where systemic oxidative stress is well-documented (Dikoma C. Shungu et al. 2012), chronically elevated ROS would provide continuous TRPA1-activating stimuli on sensory neurons and Schwann cells, sustaining neurogenic inflammation independently of mechanical or thermal triggers.
Multiple chemical sensitivity (MCS) co-occurs with ME/CFS at elevated rates. One mechanistic model proposes that MCS in ME/CFS reflects sensitization of TRPV1 and TRPA1 by prior inflammation or oxidative stress, lowering their activation thresholds below ordinary chemical concentrations (Molot, Sears, and Anisman 2023). TRPA1 is the primary sensor for fragrances, allyl isothiocyanate-containing compounds, and volatile organic chemicals; TRPV1 responds to capsaicin-like molecules and thermal/acid stimuli. In ME/CFS, chronic elevated ROS and prostaglandin production could provide the sensitizing milieu. Competing models for MCS include limbic/olfactory kindling, toxicant-induced loss of tolerance (TILT), and central olfactory sensitization; none of these models are mutually exclusive with TRP sensitization, and the mechanistic picture remains incompletely resolved.
4 Antioxidant Strategies
Multiple antioxidant interventions address different nodes of oxidative/nitrosative stress in ME/CFS:
- NAC (N-acetylcysteine): GSH precursor crossing the blood–brain barrier; 1800mg/day normalized cortical GSH and improved symptoms in pilot data (D. C. Shungu 2016).
- CoQ10 + NADH: Restores mitochondrial electron transport efficiency, reducing complex I/III electron leakage and ROS generation; RCT showed significant cognitive fatigue improvement and QoL gains.
- Melatonin: A mitochondria-targeted antioxidant that scavenges ROS and reactive nitrogen species (RNS), stimulates antioxidant enzymes (SOD, GPx, catalase) and chelates transition metals reducing hydroxyl radical production; mitochondrial concentrations greatly exceed blood levels.
Certainty: Medium individually; no multi-agent antioxidant RCT in ME/CFS has been completed. Consistent with the NO/ONOO- cycle prediction that multi-agent approaches targeting several nodes will be needed for robust benefit.